Pluri (PSTI) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 56 253 sessions, July 23, 2021 to July 25, 2022
- Largest daily move
- +24.5% close of January 10, 2022
- 1-year change
- -70.8% closing prices, July 23, 2021 to July 25, 2022
- 1-month change
- -21.3% closing prices, June 24, 2022 to July 25, 2022
Company Description
Pluri (Nasdaq: PSTI) is classified in the biotechnology industry within the Healthcare sector.
PSTI declined 70.8% in the 12 months to July 25, 2022. The last closing price was $1.00.
This page collects what Stock Titan holds for PSTI, including price data and latest news.
Stock Performance
Pluri (PSTI) closed at $1.00 on July 25, 2022. In the 12 months to July 25, 2022, the price lost 70.8%.
PSTI Metrics & Rankings
Price returns through July 25, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Pluri has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include clinical trial, partnership, covid-19. View all PSTI news →
SEC Filings
PSTI Company Profile & Sector Positioning
Pluri (PSTI) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing PSTI often look at related companies in the same sector, including NanoViricides Inc. (NNVC), Aldeyra Therapeutics, Inc. (ALDX), IRulya Therapeutics Inc. (IRLA), Impact BioMedical, Inc. (IBO), and Quince Therapeutics, Inc. (QNCX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PSTI's relative position within its industry.